Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

As 2025 kicks off there’s lots of activity in the world of IP – particularly in the Biotech and Pharma sectors, writes Marc ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

Prante Gerhard, a director at Cibus, Inc. (NASDAQ:CBUS), a small-cap biotechnology company with a market capitalization of $85.45 million, sold 1,150 shares of Class A Common Stock on February 5, 2025 ...

Guy Lawson had lunch in New York with his editors at Rolling Stone. He was tired of covering the drug wars in Mexico, and ...